(Q30360468)

20 June 2017

1 reference

title

Scientific barriers to developing vaccines against avian influenza viruses. (English)

1 reference

20 June 2017

1 reference

Kanta Subbarao

0 references

Tomy Joseph

1 reference

20 June 2017

publication date

1 April 2007

1 reference

Nature Reviews Immunology

20 June 2017

published in

1 reference

20 June 2017

1 reference

20 June 2017

1 reference

20 June 2017

page(s)

267-278

1 reference

Human illness from avian influenza H7N3, British Columbia

20 June 2017

cites work

1 reference

Recombination resulting in virulence shift in avian influenza outbreak, Chile

21 January 2018

1 reference

Transmission of Eurasian avian H2 influenza virus to shorebirds in North America.

21 January 2018

1 reference

Trials of Influenza A/New Jersey/76 Virus Vaccine in Normal Children: An Overview of Age-Related Antigenicity and Reactogenicity

21 January 2018

1 reference

Summary of Clinical Trials of Influenza Virus Vaccines in Adults

21 January 2018

1 reference

Vaccines for pandemic influenza

21 January 2018

1 reference

DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice.

21 January 2018

1 reference

Prospects for universal influenza virus vaccine

21 January 2018

1 reference

Making better influenza virus vaccines?

21 January 2018

1 reference

The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses

21 January 2018

1 reference

Novel avian influenza H7N3 strain outbreak, British Columbia

21 January 2018

1 reference

The challenge of emerging and re-emerging infectious diseases

21 January 2018

1 reference

Transmission of equine influenza virus to dogs

31 March 2020

1 reference

Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls

31 March 2020

1 reference

Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin

31 March 2020

1 reference

Virulence-associated sequence duplication at the hemagglutinin cleavage site of avian influenza viruses

31 March 2020

1 reference

Host cell proteases controlling virus pathogenicity

31 March 2020

1 reference

Is virulence of H5N2 influenza viruses in chickens associated with loss of carbohydrate from the hemagglutinin?

31 March 2020

1 reference

Phylogenetic analysis of H7 haemagglutinin subtype influenza A viruses

31 March 2020

1 reference

Low-Pathogenicity H7N2 Avian Influenza Outbreak in Virginia During 2002

31 March 2020

1 reference

Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates

31 March 2020

1 reference

Avian flu: influenza virus receptors in the human airway

31 March 2020

1 reference

H5N1 Virus Attachment to Lower Respiratory Tract

31 March 2020

1 reference

Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus

31 March 2020

1 reference

Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness

31 March 2020

1 reference

Emerging respiratory viruses: challenges and vaccine strategies

31 March 2020

1 reference

Avian flu to human influenza.

31 March 2020

1 reference

Confronting the avian influenza threat: vaccine development for a potential pandemic.

31 March 2020

1 reference

Avian influenza A (H5N1) infection in humans

31 March 2020

1 reference

Avian influenza A (H5N1).

31 March 2020

1 reference

Immunity to influenza in man

31 March 2020

1 reference

Determinants of immunity to influenza infection in man

31 March 2020

1 reference

Association of serum anti-neuraminidase antibody with resistance to influenza in man.

31 March 2020

1 reference

Continuing evolution of H9N2 influenza viruses in Southeastern China.

31 March 2020

1 reference

Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome

31 March 2020

1 reference

H1 and H7 influenza haemagglutinin structures extend a structural classification of haemagglutinin subtypes

31 March 2020

1 reference

Structural basis of immune recognition of influenza virus hemagglutinin

31 March 2020

1 reference

Effect of vaccine use in the evolution of Mexican lineage H5N2 avian influenza virus

31 March 2020

1 reference

Development of cell culture (MDCK) live cold-adapted (CA) attenuated influenza vaccine

31 March 2020

1 reference

A new European perspective of influenza pandemic planning with a particular focus on the role of mammalian cell culture vaccines.

31 March 2020

1 reference

Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants

31 March 2020

1 reference

31 March 2020

1 reference

Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses

31 March 2020

1 reference

Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics.

31 March 2020

1 reference

Eight-plasmid system for rapid generation of influenza virus vaccines

31 March 2020

1 reference

Generation of influenza A viruses entirely from cloned cDNAs

31 March 2020

1 reference

The cotton rat provides a useful small-animal model for the study of influenza virus pathogenesis.

31 March 2020

1 reference

Evidence of a cross-protective immune response to influenza A in the cotton rat model

31 March 2020

1 reference

The guinea pig as a transmission model for human influenza viruses

31 March 2020

1 reference

Generation and evaluation of a high-growth reassortant H9N2 influenza A virus as a pandemic vaccine candidate.

31 March 2020

1 reference

Immunity to influenza A H9N2 viruses induced by infection and vaccination

31 March 2020

1 reference

Immunization with reverse-genetics-produced H5N1 influenza vaccine protects ferrets against homologous and heterologous challenge.

31 March 2020

1 reference

Cross-protectiveness and immunogenicity of influenza A/Duck/Singapore/3/97(H5) vaccines against infection with A/Vietnam/1203/04(H5N1) virus in ferrets

31 March 2020

1 reference

Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system.

31 March 2020

1 reference

Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines.

31 March 2020

1 reference

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

31 March 2020

1 reference

Boosting immunity to influenza H5N1 with MF59-adjuvanted H5N3 A/Duck/Singapore/97 vaccine in a primed human population

31 March 2020

1 reference

Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations.

31 March 2020

1 reference

Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial.

31 March 2020

1 reference

Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines

31 March 2020

1 reference

Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial.

31 March 2020

1 reference

Safety and antigenicity of whole virus and subunit influenza A/Hong Kong/1073/99 (H9N2) vaccine in healthy adults: phase I randomised trial

31 March 2020

1 reference

Generation of high-yielding influenza A viruses in African green monkey kidney (Vero) cells by reverse genetics

31 March 2020

1 reference

Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.

31 March 2020

1 reference

Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

31 March 2020

1 reference

The development of live attenuated cold-adapted influenza virus vaccine for humans

31 March 2020

1 reference

Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A/Ann Arbor/6/60.

31 March 2020

1 reference

Generation and characterization of a cold-adapted influenza A H9N2 reassortant as a live pandemic influenza virus vaccine candidate.

31 March 2020

1 reference

Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets

31 March 2020

1 reference

Expression of hemagglutinin protein from the avian influenza virus H5N1 in a baculovirus/insect cell system significantly enhanced by suspension culture

31 March 2020

1 reference

Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain

31 March 2020

1 reference

Protection against H1, H5, H6 and H9 influenza A infection with liposomal matrix 2 epitope vaccines.

31 March 2020

1 reference

ISCOM vaccine induced protection against a lethal challenge with a human H5N1 influenza virus.

31 March 2020

1 reference

Impact of glycosylation on the immunogenicity of a DNA-based influenza H5 HA vaccine

31 March 2020

1 reference

Strategies for inducing protection against avian influenza A virus subtypes with DNA vaccines.

31 March 2020

1 reference

Protection against avian influenza H9N2 virus challenge by immunization with hemagglutinin- or neuraminidase-expressing DNA in BALB/c mice

31 March 2020

1 reference

Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein.

31 March 2020

1 reference

Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization

31 March 2020

1 reference

Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice.

31 March 2020

1 reference

Influenza type A virus escape mutants emerge in vivo in the presence of antibodies to the ectodomain of matrix protein 2.

31 March 2020

1 reference

Protection against influenza virus infection in BALB/c mice immunized with a single dose of neuraminidase-expressing DNAs by electroporation

31 March 2020

1 reference

Protection of mice with recombinant influenza virus neuraminidase

31 March 2020

1 reference

Development of effective vaccines against pandemic influenza.

31 March 2020

1 reference

Chimeric influenza virus hemagglutinin proteins containing large domains of the Bacillus anthracis protective antigen: protein characterization, incorporation into infectious influenza viruses, and antigenicity

31 March 2020

1 reference

Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A/Duck/Singapore/97 vaccine

31 March 2020

1 reference

Sialic acid receptor specificity on erythrocytes affects detection of antibody to avian influenza haemagglutinin.

31 March 2020

1 reference

H5N1 vaccines: how prepared are we for a pandemic?

31 March 2020

1 reference

Updating the Accounts: Global Mortality of the 1918-1920 "Spanish" Influenza Pandemic

31 March 2020

1 reference

The origin of the 1918 pandemic influenza virus: a continuing enigma.

31 March 2020

1 reference

Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus.

31 March 2020

1 reference

Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus.

31 March 2020

1 reference

Characterization of the reconstructed 1918 Spanish influenza pandemic virus

31 March 2020

1 reference

The structure and receptor binding properties of the 1918 influenza hemagglutinin

31 March 2020

1 reference

On the origin of the human influenza virus subtypes H2N2 and H3N2

31 March 2020

1 reference

Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses

31 March 2020

1 reference

Molecular characterization of H9N2 influenza viruses: were they the donors of the "internal" genes of H5N1 viruses in Hong Kong?

31 March 2020

1 reference

Characterization of the influenza A virus gene pool in avian species in southern China: was H6N1 a derivative or a precursor of H5N1?

31 March 2020

1 reference

Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates.

31 March 2020

1 reference

Genetic characterization of the pathogenic influenza A/Goose/Guangdong/1/96 (H5N1) virus: similarity of its hemagglutinin gene to those of H5N1 viruses from the 1997 outbreaks in Hong Kong

31 March 2020

1 reference

Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma

31 March 2020

1 reference

Avian influenza A (H5N1) in 10 patients in Vietnam

31 March 2020

1 reference

Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands

31 March 2020

1 reference

H9N2 influenza A viruses from poultry in Asia have human virus-like receptor specificity

31 March 2020

1 reference

Characterization of the pathogenicity of members of the newly established H9N2 influenza virus lineages in Asia

31 March 2020

1 reference

Human infection with an avian H9N2 influenza A virus in Hong Kong in 2003.

31 March 2020

1 reference

Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a potential priming strategy.

31 March 2020

1 reference

Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice.

31 March 2020

1 reference

Biologic importance of neuraminidase stalk length in influenza A virus

31 March 2020

1 reference

12 December 2020

The surface glycoproteins of H5 influenza viruses isolated from humans, chickens, and wild aquatic birds have distinguishable properties.

1 reference

12 December 2020

The role of the antibody response in influenza virus infection.

1 reference

12 December 2020

Control of avian influenza in Italy: from stamping out to emergency and prophylactic vaccination.

1 reference

12 December 2020

Immune correlates of protection against influenza in the human challenge model.

1 reference

12 December 2020

Antiviral Activity of Antiserum Specific for an Influenza Virus Neuraminidase

1 reference

12 December 2020

Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions

1 reference

12 December 2020

Atypical avian influenza (H5N1)

1 reference

12 December 2020

Avirulent Avian influenza virus as a vaccine strain against a potential human pandemic.

1 reference

12 December 2020

Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice

1 reference

12 December 2020

A single amino acid in the PB2 gene of influenza A virus is a determinant of host range.

1 reference

12 December 2020

Evolution and ecology of influenza A viruses

1 reference

12 December 2020

Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays.

1 reference

12 December 2020

Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics

1 reference

12 December 2020

A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans

1 reference

12 December 2020

Genotypic stability of cold-adapted influenza virus vaccine in an efficacy clinical trial.

1 reference

12 December 2020

Rescue of influenza A virus from recombinant DNA.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRI2054

1 reference

20 June 2017

0 references

1 reference